+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Small-Molecule APIs Market by Production Technology, Manufacturing Model, End User, Molecule Type, Route of Administration, Therapeutic Application - Global Forecast to 2030- Product Image
Small-Molecule APIs Market by Production Technology, Manufacturing Model, End User, Molecule Type, Route of Administration, Therapeutic Application - Global Forecast to 2030- Product Image
Sale

Small-Molecule APIs Market by Production Technology, Manufacturing Model, End User, Molecule Type, Route of Administration, Therapeutic Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532977
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The small-molecule APIs market is evolving rapidly against a backdrop of new technologies, changing trade dynamics, and increased global demand for high-quality active pharmaceutical ingredients. As senior leaders seek clarity amid industry transformation, authoritative insights are crucial to inform investment, supply chain, and innovation decisions.

Market Snapshot: Small-Molecule APIs Market

The Small-Molecule APIs Market grew from USD 197.35 billion in 2024 to USD 212.05 billion in 2025. It is expected to continue growing at a CAGR of 7.31%, reaching USD 301.42 billion by 2030. This advancement highlights a strong trajectory as pharmaceutical manufacturing and global healthcare requirements drive both scale and transformation within the small-molecule API industry.

Scope & Segmentation

  • Production Technology: Chemical synthesis (batch and continuous flow), fermentation, and semi-synthetic methods are critical for scalable and efficient manufacturing.
  • Manufacturing Model: Industry split between captive production by large pharmaceutical firms and merchant manufacturing serving biotechs and specialty companies.
  • End User: Key groups include biotechnology companies, contract development and manufacturing organizations, and major pharmaceutical companies.
  • Molecule Type: Segmented into branded and generic APIs, with each group facing distinct competitive and regulatory requirements.
  • Route of Administration: Includes inhalation (dry powder inhalers, metered dose inhalers, nebulizers), injectables (intramuscular, intravenous, subcutaneous), oral, and topical forms such as gels, ointments, and patches.
  • Therapeutic Application: Spans anti-infectives (antibiotics, antifungals, antivirals), cardiovascular (anticoagulant, antihypertensive), dermatology, gastrointestinal, neurology, oncology (chemotherapy, immunotherapy, targeted therapy), and respiratory diseases.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with countries such as United Kingdom, Germany, France, and others), and Asia-Pacific (including China, India, Japan, Australia, and more).
  • Key Companies: Includes Thermo Fisher Scientific Inc., Lonza Group Ltd., Wuxi AppTec Co., Ltd., Catalent, Inc., Cambrex Corporation, Evonik Industries AG, Siegfried Holding AG, Recipharm AB, Piramal Enterprises Ltd., and Divi’s Laboratories Ltd.

Key Takeaways for Decision Makers

  • Continuous flow chemistry and modular manufacturing platforms are enhancing process safety while reducing waste and time to market for small-molecule APIs.
  • Green chemistry and digital transformation are becoming central as manufacturers seek to improve environmental performance and strengthen quality control through real-time analytics.
  • Strategic diversification of manufacturing locations is a response to geopolitical and pandemic-related disruptions, ensuring resilience and continuity of supply.
  • The rise of specialized market segments—such as high-potency oncology APIs and complex inhalation therapies—presents significant opportunities for targeted innovation and premium positioning.
  • Collaborations across the value chain, including co-development partnerships and contract manufacturing, expedite pipeline progression and help manage regulatory complexities.
  • Regulatory agencies are advancing harmonized, science-based reviews, making it increasingly important for organizations to demonstrate compliance readiness and quality-focused operations.

Tariff Impact on US API Trade

Recent tariff measures on imported APIs have increased procurement costs and tightened margins in the US. Companies are reevaluating sourcing strategies by shifting production onshore, investing in advanced systems, or partnering with regional suppliers in duty-free zones. Effective inventory optimization and agile supply chain management are now essential to maintain competitiveness and safeguard against future disruptions.

Methodology & Data Sources

Findings are informed by a detailed review of industry reports, financial statements, regulatory filings, and expert interviews within the small-molecule APIs sector. Triangulation of data and peer-reviewed validation ensure accuracy and reduce bias across published insights.

Why This Report Matters

  • Supports strategic decision-making with analytical depth and actionable clarity tailored to leaders navigating dynamic market shifts.
  • Enables identification of high-growth segments, optimized manufacturing models, and effective risk mitigation strategies across regions.
  • Equips organizations to lead in an evolving marketplace by aligning operations with regulatory trends, supply chain innovations, and end-user expectations.

Conclusion

Shifting technologies, regulatory frameworks, and therapeutic needs are redefining the small-molecule APIs market. By leveraging this report’s insights, senior decision makers can proactively adapt and position their organizations for long-term strength in a complex, competitive environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Small-Molecule APIs Market, by Production Technology
8.1. Introduction
8.2. Chemical Synthesis
8.2.1. Batch Synthesis
8.2.2. Continuous Flow
8.3. Fermentation
8.4. Semi Synthetic
9. Small-Molecule APIs Market, by Manufacturing Model
9.1. Introduction
9.2. Captive
9.3. Merchant
10. Small-Molecule APIs Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Contract Development and Manufacturing Organizations
10.4. Pharmaceutical Companies
11. Small-Molecule APIs Market, by Molecule Type
11.1. Introduction
11.2. Branded
11.3. Generic
12. Small-Molecule APIs Market, by Route of Administration
12.1. Introduction
12.2. Inhalation
12.2.1. Dry Powder Inhaler
12.2.2. Metered Dose Inhaler
12.2.3. Nebulizers
12.3. Injectable
12.3.1. Intramuscular
12.3.2. Intravenous
12.3.3. Subcutaneous
12.4. Oral
12.5. Topical
12.5.1. Gels
12.5.2. Ointments
12.5.3. Patches
13. Small-Molecule APIs Market, by Therapeutic Application
13.1. Introduction
13.2. Anti Infective
13.2.1. Antibiotics
13.2.2. Antifungal
13.2.3. Antiviral
13.3. Cardiovascular
13.3.1. Anticoagulant
13.3.2. Antihypertensive
13.4. Dermatology
13.5. Gastrointestinal
13.6. Neurology
13.7. Oncology
13.7.1. Chemotherapy
13.7.2. Immunotherapy
13.7.3. Targeted Therapy
13.8. Respiratory
14. Americas Small-Molecule APIs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Small-Molecule APIs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Small-Molecule APIs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Lonza Group Ltd.
17.3.3. Wuxi AppTec Co., Ltd.
17.3.4. Catalent, Inc.
17.3.5. Cambrex Corporation.
17.3.6. Evonik Industries AG.
17.3.7. Siegfried Holding AG.
17.3.8. Recipharm AB.
17.3.9. Piramal Enterprises Ltd.
17.3.10. Divi’s Laboratories Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SMALL-MOLECULE APIS MARKET MULTI-CURRENCY
FIGURE 2. SMALL-MOLECULE APIS MARKET MULTI-LANGUAGE
FIGURE 3. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BATCH SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SEMI SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CAPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MERCHANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTICOAGULANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 89. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 90. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 95. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 98. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 99. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 166. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 169. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 171. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 175. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 178. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 179. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 182. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 186. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 188. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 191. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 205. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 207. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 208. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 210. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 212. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 213. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 214. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 216. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 217. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 218. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 221. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 223. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 225. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 226. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 227. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 230. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 270. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 273. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 275. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 279. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 281. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 282. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 296. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 298. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 299. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 301. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 302. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 303. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 304. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 305. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 307. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 308. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 309. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 312. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 314. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 315. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 316. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 317. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 318. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 320. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 321. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY MANUFACTURING MODEL, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY ANTI INFECTIVE, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Small-Molecule APIs market report include:
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • Wuxi AppTec Co., Ltd.
  • Catalent, Inc.
  • Cambrex Corporation.
  • Evonik Industries AG.
  • Siegfried Holding AG.
  • Recipharm AB.
  • Piramal Enterprises Ltd.
  • Divi’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 212.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 301.42 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Continuous Manufacturing For Small Molecule APIs Market Size, Share & Trends Analysis Report by Equipment (Reactors, Crystallizers, Filtration Systems), Unit Operation, Type, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Continuous Manufacturing For Small Molecule APIs Market Size, Share & Trends Analysis Report by Equipment (Reactors, Crystallizers, Filtration Systems), Unit Operation, Type, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Continuous Manufacturing For Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Continuous Manufacturing For Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Small Molecule aIIbß3 Antagonists Market - Global Forecast to 2030 - Product Image

Small Molecule aIIbß3 Antagonists Market - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • United States
From
Specialty Pharmaceuticals Market by Therapeutic Area, Product Type, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Specialty Pharmaceuticals Market by Therapeutic Area, Product Type, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.